Last updated: 11/03/2018 12:05:58

Quality of Life(QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatmentBRAVO

GSK study ID
111720
See study documents
Clinicaltrials.gov ID
NCT01227369
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Quality of Life(QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Trial description: Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Mean of composite satisfaction score (CSS) of OPSAT-QTM

Timeframe: 0day

Secondary outcomes:

Mean of subscale satisfaction scores of OPSAT-QTM

Timeframe: oday

Interventions:
  • Other: OPSAT-Q
    • Enrollment:
    4376
    Primary completion date:
    Not applicable
    Observational study model:
    Other
    Time perspective:
    Cross-Sectional
    Clinical publications:
    Not applicable
    Medical condition
    Osteoporosis, Postmenopausal
    Product
    Not applicable
    Collaborators
    Not applicable
    Study date(s)
    June 2008 to November 2008
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Female
    Age
    18+ years
    Accepts healthy volunteers
    No
    • Who have been diagnosed with postmenopausal osteoporosis by physician
    • Who have received any oral bisphosphonates (weekly or monthly) at least for 2 months to provide answer of OPSAT-QTM questionnaire
    • Do not understand the contents of the questionnaire
    Inclusion and exclusion criteria
    Inclusion criteria:
    • Who have been diagnosed with postmenopausal osteoporosis by physician Who have received any oral bisphosphonates (weekly or monthly) at least for 2 months to provide answer of OPSAT-QTM questionnaire Who provide informed consent for study participation
    Exclusion criteria:
    • Do not understand the contents of the questionnaire

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Seoul, South Korea, 137-701
    Status
    Study Complete
    Contact us

    Study documents

    Scientific result summary
    Available language(s): English
    Download document(s)

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    2008-20-11

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website